{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:10:30Z","timestamp":1792041030814,"version":"4.4.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in myeloid cells of the central nervous system (CNS), which mediate the immunological response in a variety of diseases. Uncertain is the function of TREM2 in glioma and tumor immune responses. In this research, the expression patterns of TREM2 in glioma were analyzed, along with its prognostic value and functional roles. TREM2 expression is increased in glioblastomas, gliomas with a mesenchymal subtype, gliomas with wild-type isocitrate dehydrogenase, and gliomas without 1p\/19q deletion, all of which suggest the aggressiveness and poor prognosis of gliomas. Gene ontology, KEGG, and Gene set variation analyses indicated that TREM2 may serve as an immune response mediator. However, the function of T cells against tumor cells was negatively correlated with TREM2, suggesting that TREM2 may suppress tumor immunity. Further investigation demonstrated a correlation between TREM2 expression and immune checkpoint expression. CIBERSORT research revealed a link between a higher TREM2 expression level and the enrichment of tumor-associated macrophages, especially M2 subtype. Single-cell analysis and multiple immunohistochemical staining results showed that microglia and macrophage cells expressed TREM2. Immunofluorescent staining indicated that knocking down the expression of TREM2 would result in a decrease in M2 polarization. TREM2 was discovered to be an independent prognostic factor in glioma. In conclusion, our findings revealed that TREM2 was significantly expressed in microglia and macrophage cells and was intimately associated with the tumor immune microenvironment. Thus, it is expected that small-molecule medications targeting TREM2 or monoclonal antibodies would enhance the efficacy of glioma immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1089266","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:37:40Z","timestamp":1673419060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["TREM2 is associated with tumor immunity and implies poor prognosis in glioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingchen","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","article-title":"Mutational landscape of secondary glioblastoma guides met-targeted trial in brain tumor","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab340","article-title":"An mri radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas","volume":"145","author":"Li","year":"2022","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20069","article-title":"Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580934","article-title":"Redox regulator glrx is associated with tumor immunity in glioma","volume":"11","author":"Chang","year":"2020","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41467-020-15129-8","article-title":"Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity","volume":"11","author":"von Roemeling","year":"2020","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy032","article-title":"Car t-cell therapy for glioblastoma: Recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro Oncol"},{"key":"B8","article-title":"Car-armed cell therapy for gliomas","volume":"9","author":"Zhai","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz212","article-title":"Immune biology of glioma-associated macrophages and microglia: Functional and therapeutic implications","volume":"22","author":"Wei","year":"2020","journal-title":"Neuro Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal trem2-dependent and trem2-independent cellular responses in alzheimer's disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02193-z","article-title":"Trem2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"Trem2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"Trem2, microglia, and neurodegenerative diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"Trem2 modulation remodels the tumor myeloid landscape enhancing anti-pd-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-022-00552-w","article-title":"Microglial tyrobp\/dap12 in alzheimer's disease: Transduction of physiological and pathological signals across trem2","volume":"17","author":"Haure-Mirande","year":"2022","journal-title":"Mol Neurodegener"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.06.023","article-title":"Dap12 couples c-fms activation to the osteoclast cytoskeleton by recruitment of syk","volume":"31","author":"Zou","year":"2008","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1759091417716610","DOI":"10.1177\/1759091417716610","article-title":"Modulation of hematopoietic lineage specification impacts trem2 expression in microglia-like cells derived from human stem cells","volume":"9","author":"Amos","year":"2017","journal-title":"ASN Neuro"},{"key":"B18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"Trem2 maintains microglial metabolic fitness in alzheimer's disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scrna-seq and intracellular protein activity reveal an immunosuppressive role of trem2 in cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41392-020-00356-8","article-title":"Trem2 marks tumor-associated macrophages","volume":"5","author":"Nakamura","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2018.01.012","article-title":"Sirna library screening identifies a druggable immune-signature driving esophageal adenocarcinoma cell growth","volume":"5","author":"Duggan","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03173-w","article-title":"Immunosuppressive trem2(+) macrophages are associated with undesirable prognosis and responses to anti-pd-1 immunotherapy in non-small cell lung cancer","volume":"71","author":"Zhang","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319227","article-title":"Trem-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms","volume":"70","author":"Esparza-Baquer","year":"2021","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse glioma heterogeneity and its therapeutic implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discovery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00090-5","article-title":"Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (catnon; eortc study 26053-22054): Second interim analysis of a randomised, open-label, phase 3 study","volume":"22","author":"van den Bent","year":"2021","journal-title":"Lancet Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707358","article-title":"Lomustine and bevacizumab in progressive glioblastoma","volume":"377","author":"Wick","year":"2017","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-pd-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-pd-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e137407","DOI":"10.1172\/JCI137407","article-title":"Trem-2 promotes th1 responses by interacting with the cd3zeta-zap70 complex following mycobacterium tuberculosis infection","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","article-title":"The microglial innate immune receptor trem2 is required for synapse elimination and normal brain connectivity","volume":"48","author":"Filipello","year":"2018","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.10.011","article-title":"Triggering receptor expressed on myeloid cells 2 (trem2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice","volume":"68","author":"Hu","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.676744","article-title":"Temporal ordering of inflammatory analytes stnfr2 and strem2 in relation to alzheimer's disease biomarkers and clinical outcomes","volume":"13","author":"Pillai","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e85841","DOI":"10.1172\/jci.insight.85841","article-title":"Glioblastoma-infiltrated innate immune cells resemble m0 macrophage phenotype","volume":"1","author":"Gabrusiewicz","year":"2016","journal-title":"JCI Insight"},{"key":"B35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"Muller","year":"2017","journal-title":"Genome Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"n1560","DOI":"10.1136\/bmj.n1560","article-title":"Glioblastoma: Clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"BMJ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: A society for neuro-oncology (sno) and european society of neuro-oncology (eano) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-016-0362-7","article-title":"The comparison of clinical and biological characteristics between idh1 and idh2 mutations in gliomas","volume":"35","author":"Wang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz102","article-title":"Systematically characterize the clinical and biological significances of 1p19q genes in 1p\/19q non-codeletion glioma","volume":"40","author":"Chai","year":"2019","journal-title":"Carcinogenesis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in pdgfra, idh1, egfr, and nf1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using david bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1328339","DOI":"10.1080\/2162402X.2017.1328339","article-title":"Molecular and clinical characterization of tim-3 in glioma through 1,024 samples","volume":"6","author":"Li","year":"2017","journal-title":"Oncoimmunology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using umap","author":"Becht","year":"2018","journal-title":"Nat Biotechnol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1089266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:37:43Z","timestamp":1673419063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1089266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2022.1089266"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1089266","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"article-number":"1089266"}}